Cutler Group LP Alector, Inc. Put Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Apr 14, 2022	SELL	$13.02 - $20.78 $28,644 - $45,716	-2,200 Reduced 91.67%	200 $0
Q4 2021 Jan 18, 2022	SELL	$19.35 - $25.54 $54,180 - $71,512	-2,800 Reduced 53.85%	2,400 $17,000
Q3 2021 Oct 26, 2021	BUY	$21.65 - $39.49 $110,415 - $201,399	5,100 Added 5100.0%	5,200 $48,000
Q2 2021 Jul 19, 2021	SELL	$15.5 - $22.48 $13,950 - $20,232	-900 Reduced 90.0%	100 $0
Q1 2021 Apr 26, 2021	SELL	$14.84 - $22.23 $5,936 - $8,892	-400 Reduced 28.57%	1,000 $0

Q4 2020 Jan 21, 2021	BUY	$9.4 - $16.7 $1,880 - $3,340	200 Added 16.67%	1,400 $5,000
Q3 2020 Oct 27, 2020	SELL	$10.54 - $24.96 $5,270 - $12,480	-500 Reduced 29.41%	1,200 $6,000
Q2 2020 Jul 22, 2020	SELL	$21.87 - $33.11 $32,805 - $49,665	-1,500 Reduced 46.88%	1,700 $11,000
Q1 2020 May 07, 2020	BUY	$16.25 - $35.28 $52,000 - $112,896	3,200 New	3,200 $21,000

161

59.8M

67.8K

200

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $364M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.